The authors say: 'The data are not so robust because of heterogeneity' - So, how should I deal with this systematic review?: Meta-analysis and the clinician

Cerebrovascular Diseases

Volumn 31, Issue 6, 2011, Pages 615-620

  Sandercock, Peter ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Heterogeneity; Meta analysis; Systematic review

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; DESMOTEPLASE; HEPARIN; PROUROKINASE; STREPTOKINASE; UROKINASE;

ARTICLE; DATA ANALYSIS; FIBRINOLYTIC THERAPY; HUMAN; MEDICAL RESEARCH; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STROKE; SYSTEMATIC REVIEW (TOPIC);

CEREBROVASCULAR DISORDERS; DATA INTERPRETATION, STATISTICAL; HUMANS; META-ANALYSIS AS TOPIC; REVIEW LITERATURE AS TOPIC;

EID: 79953874255     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000326068     Document Type: Article

References (6)

1. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2. 2009. www. cochrane-handbook.org.
2. Wardlaw JM, Murray V, Berge E, del Zoppo GJ: Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2009; 4:CD000213.
3. Collins R, MacMahon S: Reliable assessment of the effects of treatment on mortality and major morbidity. 1. Clinical trials. Lancet 2001; 357: 373-380. (Pubitemid 32128549)
4. Schulz KF, Grimes DA: Multiplicity in randomised trials. 2. Subgroup and interim analyses. Lancet 2005; 365: 1657-1661. (Pubitemid 40693416)
5. Counsell CE, Clarke MJ, Slattery J, Sandercock PA: The miracle of DICE therapy for acute stroke: fact or fictional product of subgroup analysis? BMJ 1994; 309: 1677-1681.
6. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W, ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group, Allen K, Mau J, Meier D, del Zoppo G, de Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G: Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375: 1695-1703.